Interpreting Sameness of Monoclonal Antibody Products Under the Orphan Drug Regulations
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 1, 2014
December 1, 2018
31a4f2ab-649f-4be4-af24-4229e9d753c7
Related Documents
ANDAs: Stability Testing of Drug Substances and Products, Questions and Answers
Guidance DocumentMay 15, 2014Center for Drug Evaluation and Research
Immunogenicity Assessment for Therapeutic Protein Products
Guidance DocumentAugust 14, 2014Center for Drug Evaluation and Research
ANDAs: Stability Testing of Drug Substances and Products
Guidance DocumentJune 20, 2013Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox